- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glomerulonephritis in United States
Total 223 results
-
AmgenCompletedSystemic Lupus Erythematosus | NephritisUnited States, Hong Kong, France, Malaysia, Mexico
-
Artiva Biotherapeutics, Inc.RecruitingLupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIUnited States
-
EMD SeronoZymoGeneticsTerminatedLupus NephritisUnited States, Singapore, Malaysia, Taiwan, Czech Republic
-
University of MinnesotaUnited States Department of DefenseRecruitingFocal Segmental GlomerulosclerosisUnited States
-
Boehringer IngelheimCompletedLupus NephritisUnited Kingdom, Thailand, Germany, Japan, United States, Australia, Korea, Republic of, Hong Kong, Poland, Greece, Mexico, Czechia, Canada, Malaysia, Philippines, Portugal
-
TakedaActive, not recruitingGlomerulonephritis | Kidney DiseaseTaiwan, Australia, Hungary, Spain, United Kingdom, United States, China, Korea, Republic of, Italy, Japan, Singapore
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedLupus Erythematosus, Systemic | Lupus NephritisUnited States, Mexico
-
Northwell HealthTerminatedCardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental GlomerulosclerosisChronic Kidney Disease | Focal Segmental Glomerulosclerosis | Nephrotic Syndrome | Steroid Resistant Nephrotic SyndromeUnited States
-
TakedaTerminatedLupus NephritisUnited States, France, United Kingdom, Germany, Spain, Russian Federation, Italy
-
TakedaNot yet recruitingRefractory Lupus NephritisUnited States
-
National Institute of Diabetes and Digestive and...CompletedProteinuria | Albuminuria | HIV-Associated Focal Segmental Glomerulosclerosis | Renal Tubular Toxicity | HIV-Associated Collapsing GlomerulopathyUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedA Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus NephritisLupus NephritisUnited States, Canada, France, Russian Federation, United Kingdom
-
University of MichiganCompletedFocal Segmental Glomerulosclerosis | Minimal Change Disease | FSGS | MCDUnited States
-
Northwell HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingFocal Segmental Glomerulosclerosis | Minimal Change Disease | Nephrotic Syndrome in ChildrenUnited States
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsRecruitingLupus NephritisUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedGlomerulosclerosis, Focal SegmentalUnited States, France, United Kingdom, Puerto Rico
-
Northwell HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingFocal Segmental Glomerulosclerosis | Minimal Change Disease | Nephrotic Syndrome in ChildrenUnited States
-
Janssen Research & Development, LLCCompletedLupus NephritisUnited States, Belgium, Mexico, Poland, Netherlands, Thailand
-
GlaxoSmithKlineRecruitingSystemic Lupus ErythematosusUnited Arab Emirates
-
AstraZenecaParexelCompletedLupus NephritisUnited States, Italy, Spain, Taiwan, Peru, Belgium, France, Korea, Republic of, Mexico, Germany, Australia, Hungary, Serbia, Russian Federation, United Kingdom, Poland, Argentina
-
ImmPACT BioRecruitingSystemic Lupus Erythematosus | Lupus NephritisUnited States
-
Baxalta now part of ShireTerminatedSystemic Lupus ErythematosusAustralia, United States, New Zealand, Mexico, Canada
-
Bristol-Myers SquibbCompletedFocal Segmental Glomerulosclerosis | Nephrotic Syndrome | Minimal Change DiseaseUnited States
-
ChemoCentryxMedpace, Inc.CompletedFocal Segmental Glomerulosclerosis | FSGS | GlomerulosclerosisUnited States, France, Italy, Australia, United Kingdom, Canada, New Zealand, Poland
-
Novartis PharmaceuticalsCompletedLupus NephritisFrance, Spain, Colombia, Hungary, Italy, Germany, Greece, Taiwan, United Kingdom
-
Boehringer IngelheimCompletedLupus NephritisSpain, United Kingdom, United States, Canada, Thailand, Germany, Italy, Japan, Serbia, Australia, Korea, Republic of, Mexico, Malaysia, Philippines, Poland, Portugal, Greece, Hong Kong, Czechia, France
-
BiogenTerminatedLupus NephritisBelgium, Peru, Italy, Malaysia, Australia, Argentina, United States, Hong Kong, Hungary, Poland, Colombia, Russian Federation, Philippines, Brazil, France, Korea, Republic of, Mexico, Spain, Thailand
-
Janssen Research & Development, LLCNot yet recruitingLupus NephritisUnited States
-
Astellas Pharma Global Development, Inc.Kyowa Kirin Co., Ltd.CompletedKidney Transplantation | Primary Focal Segmental Glomerulosclerosis (FSGS)United States, Canada
-
Mallinckrodt ARD LLCCompletedIdiopathic Focal Segmental GlomerulosclerosisUnited States, Argentina, Turkey, Peru, Australia, Chile, Mexico
-
Bristol-Myers SquibbTerminatedLupus NephritisUnited States, Taiwan, Spain, United Kingdom, Netherlands, Germany, China, Australia, Belgium, Mexico, Korea, Republic of, Czechia, Russian Federation, Israel, Canada, Italy
-
Hoffmann-La RocheAspreva PharmaceuticalsCompletedLupus NephritisBelgium, Germany, Italy, Spain, Canada, France, Portugal, United States, Greece, Mexico, United Kingdom, Australia, China, Hungary, Argentina, Brazil, Czech Republic
-
Aurinia Pharmaceuticals Inc.CompletedLupus NephritisUnited States, Bangladesh, Belarus, Bulgaria, China, Ecuador, Georgia, Guatemala, Korea, Republic of, Mexico, Philippines, Poland, Russian Federation, Serbia, Singapore, Spain, Sri Lanka, Taiwan, Thailand, Ukraine
-
HI-BioRecruitingLupus NephritisUnited States, Argentina, Australia
-
BiogenTerminatedLupus NephritisUnited States, Peru, Belgium, Italy, Philippines, Malaysia, Hong Kong, Argentina, Germany, Hungary, Australia, Colombia, Russian Federation, Portugal, Mexico, Korea, Republic of, France, Thailand, Brazil, Poland, Spain
-
Imperial College LondonKarolinska Institutet; Ohio State University; Dutch Working Party on Systemic... and other collaboratorsTerminatedSystemic Lupus Erythematosus, Lupus NephritisUnited Kingdom
-
Travere Therapeutics, Inc.CompletedFocal Segmental GlomerulosclerosisUnited States, Italy, Czechia
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedLupus NephritisUnited States, Korea, Republic of, Spain, Mexico, Philippines, Thailand, France, Germany, Belgium, Hong Kong, Taiwan, Canada, China, Argentina, United Kingdom, Brazil, Colombia, Czechia, Hungary, Netherlands, Russian Federation
-
Cabaletta BioRecruitingSystemic Lupus Erythematosus | Lupus NephritisUnited States
-
National Institute of Allergy and Infectious Diseases...Active, not recruiting
-
Bristol-Myers SquibbTerminatedLupus NephritisAustralia, China, Italy, Taiwan, Turkey, United States, Hong Kong, Spain, Russian Federation, Korea, Republic of, Japan, Israel, Romania, Puerto Rico, Argentina, Brazil, Canada, Chile, Colombia, Czechia, India, Mexico, Peru
-
All Natural Medicine Clinic, LLCRecruitingDepression | Anxiety Disorders | Hepatitis | Insomnia | Gastro Esophageal Reflux | GERD | Glomerulonephritis | Depression, Anxiety | Depression, Bipolar | Sequelae of; Infection | Post Infection Glomerulonephritis | Post-Infectious Peripheral Neuralgia | Post-Infectious Disorder (Disorder) | Post-Infectious Arthritis and other conditionsUnited States
-
Aurinia Pharmaceuticals Inc.CompletedLupus NephritisUnited States, Argentina, Belarus, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, Croatia, Dominican Republic, Guatemala, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, North Macedonia, Peru, Philippines, Poland, Puerto Rico and more
-
La Jolla Pharmaceutical CompanyTerminatedLupus Erythematosus, Systemic | Lupus NephritisTaiwan, United States, Belarus, Serbia, Czech Republic, Philippines, Lebanon, India, Korea, Republic of, Argentina, Australia, Brazil, Bulgaria, Georgia, Germany, Hong Kong, Hungary, Indonesia, Italy, Malaysia, Mexico, Poland, Portugal and more
-
Goldfinch Bio, Inc.TerminatedDiabetic Nephropathies | Glomerulosclerosis, Focal Segmental | Minimal Change DiseaseUnited States
-
Travere Therapeutics, Inc.Active, not recruitingFocal Segmental GlomerulosclerosisUnited States, Australia, Belgium, Croatia, Estonia, Germany, Hong Kong, Italy, Korea, Republic of, Poland, Portugal, Spain, Taiwan, United Kingdom, Argentina, Brazil, Canada, Czechia, Denmark, France, New Zealand, Sweden
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - World Health Organization (WHO) Class III | Lupus Nephritis - WHO Class IVUnited States
-
PfizerTerminatedFocal Segmental Glomerulosclerosis (FSGS)United States, Spain, Czechia, Canada, France, Germany, United Kingdom, Poland, Japan, Mexico, Italy, Slovakia
-
Chinook Therapeutics U.S., Inc.Active, not recruitingDiabetic Kidney Disease | Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | IgA Nephropathy | Diabetic Nephropathy Type 2 | Alport SyndromeUnited States, Spain, Korea, Republic of, Australia, Italy, United Kingdom
-
Hoffmann-La RocheGenentech, Inc.RecruitingLupus NephritisUnited States, Brazil, Canada, France, Italy, Peru, Poland, South Africa, Spain, United Kingdom, Mexico, Russian Federation